Celltrion
068270.KS
#754
Rank
ยฃ20.72 B
Marketcap
ยฃ100.04
Share price
0.72%
Change (1 day)
1.80%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ11.23 Billion

According to Celltrion 's latest financial reports the company's total assets are ยฃ11.23 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31ยฃ3.86 B9.33%
2021-12-31ยฃ3.53 B4.21%
2020-12-31ยฃ3.38 B33.18%
2019-12-31ยฃ2.54 B2.96%
2018-12-31ยฃ2.47 B8.13%
2017-12-31ยฃ2.28 B17.92%
2016-12-31ยฃ1.93 B27.87%
2015-12-31ยฃ1.51 B11.34%
2014-12-31ยฃ1.36 B19.71%
2013-12-31ยฃ1.13 B10.15%
2012-12-31ยฃ1.03 B32.25%
2011-12-31ยฃ0.78 B17.6%
2010-12-31ยฃ0.66 B121.21%
2009-12-31ยฃ0.30 B9.47%
2008-12-31ยฃ0.27 B721.14%
2007-12-31ยฃ33.39 M